Phase I clinical trial of liposomal-encapsulated doxorubicin citrate and docetaxel, associated with trastuzumab, as neo-adjuvant treatment in stages II and IIIA, HER2-overexpressing breast cancer patients. GEICAM 2003-03 study. - Anton,A..; Ruiz,A..; Segui,M.A.; Calvo,L..; Munoz,M..; Lao,J..; et,al.. (Ann Oncol, 2009)